6

Mar, 2020

Penta at CROI 2020

Tags: , ,

The annual Conference on Retroviruses and Opportunistic Infections (CROI) will be held from March 8 to 11 in Boston, Massachusetts.

CROI brings together top basic, translational, and clinical researchers from around the world to share the latest studies, important developments, and best research methods in the ongoing battle against HIV/AIDS and related infectious diseases.

READ MORE

6

Mar, 2020

10th International Workshop on HIV & Women

Tags:

The 10th international workshop on HIV and women is taking place in Boston, MA, USA on March 6-7. This is an outstanding opportunity for health care providers, researchers, government, industry and community to discuss, debate, and further their knowledge on the issues related to HIV and women.  The format of the meeting enables attendees to learn from experts in the field of HIV and related health, and then to dialogue on the issues, the gaps and the opportunities for further learning and research.  Many of the attendees come each year […]

READ MORE

4

Mar, 2020

Penta at 10th International Workshop on HIV & Women

Tags: ,

The 10th International Workshop on HIV & Women is in Boston on 6 – 7 March 2020, just prior to CROI. This is an outstanding opportunity for health care providers, researchers, government, industry and community representatives to discuss, debate, and increase their knowledge on HIV and its burden on women. 

READ MORE

19

Feb, 2020

New publications from EPIICAL Consortium

Tags: , ,

Just published – data on T & B cell memory and T cell function in early-treated children in the Journal of Immunology and AIDS. Antiretroviral treatment (if started at an early stage) is able to reduce the amount of HIV virus in a child’s body. EPIICAL is studying the characteristics of the immune response and the amount of HIV virus, in children with HIV who are treated at an early stage. This is to outline treatment strategies to help find a cure for HIV. Congratulations to all the authors!

READ MORE

19

Feb, 2020

Impact of early antiretroviral therapy initiation on HIV-specific CD4 and CD8 T cell function in perinatally infected children

Tags: ,

Authors: Rinaldi S, Pallikkuth S, Cameron M, et al. Published in: J Immunol. 2020 Feb 1;204:540-549 Abstract Early initiation of antiretroviral therapy (ART) in vertically HIV-infected children limits the size of the virus reservoir, but whether the time of treatment initiation (TI) can durably impact host immune responses associated with HIV infection is still unknown. This study was conducted in PBMC of 20 HIV-infected virally suppressed children on ART (mean age 9.4 y), classified as early treated (ET; age at ART initiation ≤0.5 y, n = 14) or late treated (LT; […]

READ MORE